Timing and deepness of response to tyrosine kinase inhibitors as a measure of potential treatment discontinuation in chronic myeloid leukemia patients managed in the real-life.
Massimo BrecciaGioia ColafigliMatteo MolicaEmilia ScalzulliDaniela DiverioRoberto LatagliataAnna GuariniRobin FoàPublished in: American journal of hematology (2017)